Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of 0.5% cannabidiol in alcohol solution versus alcohol solution on skin barrier function
TCTR20230110001Phase 3Completed
- Sponsor
- Thammasat University
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cannabidiol in Epidermal barrier dysfunction (2 arms), sponsored by Thammasat University. Started Jun 2023; status: completed.
02
Drugs
cannabidiol
03
Conditions
Epidermal barrier dysfunction
Beyond the preview
Go deeper on TCTR20230110001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230110001.